ABL Bio (XKRX:298380) Other Operating Expense : ₩8,133 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Other Operating Expense?

ABL Bio's Other Operating Expense for the three months ended in Mar. 2024 was ₩2,041 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩8,133 Mil.

ABL Bio's quarterly Other Operating Expense increased from Sep. 2023 (₩1,773 Mil) to Dec. 2023 (₩2,378 Mil) but then declined from Dec. 2023 (₩2,378 Mil) to Mar. 2024 (₩2,041 Mil).

ABL Bio's annual Other Operating Expense declined from Dec. 2021 (₩10,167 Mil) to Dec. 2022 (₩9,125 Mil) and declined from Dec. 2022 (₩9,125 Mil) to Dec. 2023 (₩8,196 Mil).

ABL Bio Other Operating Expense Historical Data

The historical data trend for ABL Bio's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Other Operating Expense Chart

ABL Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

7,516.89

9,641.13

10,166.78

9,124.63

8,196.13

ABL Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															2,104.28	1,940.64	1,772.82	2,378.39	2,041.44

ABL Bio Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,133 Mil.

ABL Bio Other Operating Expense Related Terms

Thank you for viewing the detailed overview of ABL Bio's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio (XKRX:298380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

https://www.ablbio.com

ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines